医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians.

广告
第一作者: Luca,Hensen
第一单位: Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia.
作者单位: Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia. [1] World Health Organization Collaborating Centre for Reference and Research on Influenza, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia. [2] Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia.;Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands. [3] Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia. [4] Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.;Center for Global Infectious Disease Research (CGIDR), Seattle Children's Research Institute, Seattle, WA 98109. [5] Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.;Immunology Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4029, Australia. [6] Immune Therapies Laboratory, Burnet Institute, Melbourne, VIC 3084, Australia.;Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC 3010, Australia.;Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia. [7] Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, TAS 7250, Australia.;School of Health Sciences and School of Medicine, University of Tasmania, Launceston, TAS 7248, Australia.;Department of Immunology and Pathology, Monash University, Melbourne, VIC 3800, Australia.;School of Health and Biomedical Science, Royal Melbourne Institute of Technology, Melbourne, VIC 3000, Australia. [8] School of Health and Biomedical Science, Royal Melbourne Institute of Technology, Melbourne, VIC 3000, Australia. [9] Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia.;Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC 3010, Australia. [10] Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia.;Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC 3010, Australia.;Infectious Diseases Department, Melbourne Sexual Health Centre, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC 3053, Australia. [11] Indigenous Engagement, Central Queensland University, Townsville, QLD 4810, Australia. [12] Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia; pcd@unimelb.edu.au kkedz@unimelb.edu.au.;Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105. [13] Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.;Department of Infectious Diseases, Royal Darwin Hospital, Darwin, NT 0810, Australia. [14] Menzies School of Health Research, Charles Darwin University, Darwin, NT 0810, Australia.;Victorian Infectious Diseases Service, The Royal Melbourne Hospital and The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia. [15] Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia; pcd@unimelb.edu.au kkedz@unimelb.edu.au. [16]
DOI 10.1073/pnas.2109388118
PMID 34607957
发布时间 2021-12-14
提交
  • 浏览3
Proceedings of the National Academy of Sciences of the United States of America

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷